{"id":7242,"date":"2025-08-25T11:23:58","date_gmt":"2025-08-25T03:23:58","guid":{"rendered":"https:\/\/www.transplantation.com.cn\/?p=7242"},"modified":"2025-08-25T11:37:25","modified_gmt":"2025-08-25T03:37:25","slug":"%e5%af%bc%e8%87%b4%e8%82%ba%e7%82%8e%e8%87%b4%e6%ad%bb%e9%a3%8e%e9%99%a9%e4%b8%8a%e5%8d%87%ef%bc%8c%e8%bf%98%e5%bd%b1%e5%93%8d%e6%89%8b%e6%9c%af%e5%8c%96%e7%96%97%ef%bc%8c%e5%85%a8%e7%90%83%e5%81%a5","status":"publish","type":"post","link":"https:\/\/www.transplantation.com.cn\/en_US\/2025\/08\/25\/%e5%af%bc%e8%87%b4%e8%82%ba%e7%82%8e%e8%87%b4%e6%ad%bb%e9%a3%8e%e9%99%a9%e4%b8%8a%e5%8d%87%ef%bc%8c%e8%bf%98%e5%bd%b1%e5%93%8d%e6%89%8b%e6%9c%af%e5%8c%96%e7%96%97%ef%bc%8c%e5%85%a8%e7%90%83%e5%81%a5\/","title":{"rendered":"Increased risk of pneumonia-related mortality and impact on surgical\/chemotherapy outcomes: New therapy emerges for a persistent global health challenge."},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n
\n

Bacteriophage therapy has emerged as one of the most promising alternative antimicrobial approaches.<\/p>\n<\/blockquote>\n\n\n\n

\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n

Currently, the global rise in antibiotic-resistant infections is escalating, with conventional antibiotics becoming increasingly ineffective and the threat of “superbugs” intensifying. This not only elevates mortality risks from common illnesses like pneumonia but also compromises medical procedures such as surgeries and chemotherapy due to infection concerns.<\/p>\n\n\n\n

From August 19 to 23, 2025, the China Society of Biotechnology\u2019s Phage Conference & the 8th China Phage Therapy Conference was held at Zhongshan Hospital, Fudan University. A key highlight from the event was the announcement that bacteriophage therapy\u2014a treatment specifically targeting bacteria\u2014is emerging as one of the most promising alternative approaches to combat antimicrobial resistance.<\/p>\n\n\n\n

\"\"\/<\/figure>\n\n\n\n

As one of China\u2019s most large-scale and influential annual academic conferences in the field of phage research and clinical applications, this year\u2019s event focused on advancing the construction of a phage therapy system, offering new solutions to tackle the global public health challenge of antibiotic resistance.<\/p>\n\n\n\n

During the conference, the 2025 National Key R&D Program \u201cFrontier Biotechnology\u201d launched two major phage-specific initiatives:<\/p>\n\n\n\n